| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adjuvant treatment patterns and outcomes in patients with stage IB-IIIA non-small cell lung cancer in France, Germany, and the United Kingdom based on the LuCaBIS burden of illness study
|
Chouaid, Christos
|
|
2018
|
124 |
C |
p. 310-316
|
artikel
|
| 2 |
A new bronchoscopic catheter for the transbronchial ablation of pulmonary nodules
|
Safi, Seyer
|
|
2018
|
124 |
C |
p. 125-129
|
artikel
|
| 3 |
Antibody drug conjugates in thoracic malignancies
|
Pacheco, Jose M.
|
|
2018
|
124 |
C |
p. 260-269
|
artikel
|
| 4 |
A phase II randomized trial of adjuvant chemotherapy with S-1 versus S-1 plus cisplatin for completely resected pathological stage II/IIIA non-small cell lung cancer
|
Okamoto, Tatsuro
|
|
2018
|
124 |
C |
p. 255-259
|
artikel
|
| 5 |
Applicability of a prognostic CT-based radiomic signature model trained on stage I-III non-small cell lung cancer in stage IV non-small cell lung cancer
|
de Jong, Evelyn E.C.
|
|
2018
|
124 |
C |
p. 6-11
|
artikel
|
| 6 |
Automated chromogenic multiplexed immunohistochemistry assay for diagnosis and predictive biomarker testing in non-small cell lung cancer
|
Ilie, Marius
|
|
2018
|
124 |
C |
p. 90-94
|
artikel
|
| 7 |
Bcl-2 expression in circulating tumor cells (CTCs) of patients with small cell lung cancer (SCLC) receiving front-line treatment
|
Messaritakis, Ippokratis
|
|
2018
|
124 |
C |
p. 270-278
|
artikel
|
| 8 |
CAPACITY: A physical activity self-management program for patients undergoing surgery for lung cancer, a phase I feasibility study
|
Granger, Catherine L.
|
|
2018
|
124 |
C |
p. 102-109
|
artikel
|
| 9 |
Carving out another slice of the pie: Exceptional response to single agent imatinib in an asian female never-smoker with advanced NSCLC with a de-novo PDGFR-α N848 K mutation
|
Klempner, Samuel J.
|
|
2018
|
124 |
C |
p. 86-89
|
artikel
|
| 10 |
Change in the lymphocyte-to-monocyte ratio is an early surrogate marker of the efficacy of nivolumab monotherapy in advanced non-small-cell lung cancer
|
Sekine, Katsutoshi
|
|
2018
|
124 |
C |
p. 179-188
|
artikel
|
| 11 |
Circulating endothelial cells and microparticles as diagnostic and prognostic biomarkers in small-cell lung cancer
|
Najjar, Fadi
|
|
2018
|
124 |
C |
p. 23-30
|
artikel
|
| 12 |
Contents
|
|
|
2018
|
124 |
C |
p. v-viii
|
artikel
|
| 13 |
Continuation of gefitinib beyond progression in patients with EGFR mutation-positive non-small-cell lung cancer: A phase II single-arm trial
|
Lim, Sung Won
|
|
2018
|
124 |
C |
p. 293-297
|
artikel
|
| 14 |
Cost-effectiveness of a low-dose computed tomography screening programme for lung cancer in New Zealand
|
Jaine, Richard
|
|
2018
|
124 |
C |
p. 233-240
|
artikel
|
| 15 |
Cost-effectiveness of pembrolizumab as first-line therapy for advanced non-small cell lung cancer
|
Georgieva, Mina
|
|
2018
|
124 |
C |
p. 248-254
|
artikel
|
| 16 |
Cost-utility analysis of a potential lung cancer screening program for a high-risk population in Germany: A modelling approach
|
Hofer, Florian
|
|
2018
|
124 |
C |
p. 189-198
|
artikel
|
| 17 |
Crizotinib treatment for patients with EGFR mutation positive NSCLC that acquire cMET amplification after EGFR TKI therapy results in short-lived and heterogeneous responses
|
van Veggel, Bianca
|
|
2018
|
124 |
C |
p. 130-134
|
artikel
|
| 18 |
Current efforts in research of pleural mesothelioma—An analysis of the ClinicalTrials.gov registry
|
Süveg, Krisztian
|
|
2018
|
124 |
C |
p. 12-18
|
artikel
|
| 19 |
Definitive treatment patterns and survival in stage II non-small cell lung cancer
|
Yan, Sherry X.
|
|
2018
|
124 |
C |
p. 135-142
|
artikel
|
| 20 |
Does presentation at multidisciplinary team meetings improve lung cancer survival? Findings from a consecutive cohort study
|
Stone, Emily
|
|
2018
|
124 |
C |
p. 199-204
|
artikel
|
| 21 |
Dose escalation and associated predictors of survival with consolidative thoracic radiotherapy in extensive stage small cell lung cancer (SCLC): A National Cancer Database (NCDB) propensity-matched analysis
|
Hasan, Shaakir
|
|
2018
|
124 |
C |
p. 283-290
|
artikel
|
| 22 |
Economic burden of resected (stage IB-IIIA) non-small cell lung cancer in France, Germany and the United Kingdom: A retrospective observational study (LuCaBIS)
|
Andreas, Stefan
|
|
2018
|
124 |
C |
p. 298-309
|
artikel
|
| 23 |
Editorial Board
|
|
|
2018
|
124 |
C |
p. iii
|
artikel
|
| 24 |
EGFR and HER3 signaling blockade in invasive mucinous lung adenocarcinoma harboring an NRG1 fusion
|
Kim, Hye Sook
|
|
2018
|
124 |
C |
p. 71-75
|
artikel
|
| 25 |
Elongation factor-2 kinase (eEF-2K) expression is associated with poor patient survival and promotes proliferation, invasion and tumor growth of lung cancer
|
Bircan, Haci Ahmet
|
|
2018
|
124 |
C |
p. 31-39
|
artikel
|
| 26 |
Establishment of a platform of non-small-cell lung cancer patient-derived xenografts with clinical and genomic annotation
|
Kang, Han Na
|
|
2018
|
124 |
C |
p. 168-178
|
artikel
|
| 27 |
Exosomal RNA-profiling of pleural effusions identifies adenocarcinoma patients through elevated miR-200 and LCN2 expression
|
Hydbring, Per
|
|
2018
|
124 |
C |
p. 45-52
|
artikel
|
| 28 |
Heterogeneous MET gene copy number and EGFR mutation elicit discordant responses to crizotinib between primary and metastatic lesions in erlotinib-resistant lung adenocarcinoma
|
Yoshimura, Katsuhiro
|
|
2018
|
124 |
C |
p. 317-319
|
artikel
|
| 29 |
Highlights of the 14th international mesothelioma interest group meeting: Pathologic separation of benign from malignant mesothelial proliferations and histologic/molecular analysis of malignant mesothelioma subtypes
|
Churg, Andrew
|
|
2018
|
124 |
C |
p. 95-101
|
artikel
|
| 30 |
High-throughput sequencing reveals distinct genetic features and clinical implications of NSCLC with de novo and acquired EGFR T790M mutation
|
Tian, Panwen
|
|
2018
|
124 |
C |
p. 205-210
|
artikel
|
| 31 |
Implementation of optimized supportive care and hospital needs along the management of patients with advanced lung cancer
|
Lafitte, Claire
|
|
2018
|
124 |
C |
p. 143-147
|
artikel
|
| 32 |
In Regard to Robinson et al: Induction chemoradiotherapy versus chemotherapy alone for superior sulcus lung cancer
|
Dickhoff, C.
|
|
2018
|
124 |
C |
p. 320-321
|
artikel
|
| 33 |
Intratumoral heterogeneity of copy number variation in lung cancer harboring L858R via immunohistochemical heterogeneous staining
|
Hashimoto, Takafumi
|
|
2018
|
124 |
C |
p. 241-247
|
artikel
|
| 34 |
Invasive nodal evaluation prior to stereotactic ablative radiation for non-small cell lung cancer
|
Harris, Jeremy P.
|
|
2018
|
124 |
C |
p. 76-85
|
artikel
|
| 35 |
KRAS-Mutant non-small cell lung cancer: From biology to therapy
|
Ferrer, Irene
|
|
2018
|
124 |
C |
p. 53-64
|
artikel
|
| 36 |
Lung cancer CT screening: Psychological responses in the presence and absence of pulmonary nodules
|
Clark, Marcia E.
|
|
2018
|
124 |
C |
p. 160-167
|
artikel
|
| 37 |
Mechanisms of primary resistance to EGFR targeted therapy in advanced lung adenocarcinomas
|
Jin, Ying
|
|
2018
|
124 |
C |
p. 110-116
|
artikel
|
| 38 |
Multisite stereotactic body radiotherapy for metastatic non-small-cell lung cancer: Delaying the need to start or change systemic therapy?
|
Merino Lara, Tomas
|
|
2018
|
124 |
C |
p. 219-226
|
artikel
|
| 39 |
Non-invasive detection of actionable mutations in advanced non-small-cell lung cancer using targeted sequencing of circulating tumor DNA
|
Sim, Wey Cheng
|
|
2018
|
124 |
C |
p. 154-159
|
artikel
|
| 40 |
Novel gene mutations in well-differentiated fetal adenocarcinoma of the lung in the next generation sequencing era
|
Fu, Yiyun
|
|
2018
|
124 |
C |
p. 1-5
|
artikel
|
| 41 |
Phase II trial of gefitinib plus pemetrexed after relapse using first-line gefitinib in patients with non-small cell lung cancer harboring EGFR gene mutations
|
Uchibori, Ken
|
|
2018
|
124 |
C |
p. 65-70
|
artikel
|
| 42 |
Probable hereditary familial overlap syndrome with multiple synchronous lung tumors
|
Cardona, Andrés F.
|
|
2018
|
124 |
C |
p. 279-282
|
artikel
|
| 43 |
Rare targetable drivers (RTDs) in non-small cell lung cancer (NSCLC): Outcomes with immune check-point inhibitors (ICPi)
|
Dudnik, Elizabeth
|
|
2018
|
124 |
C |
p. 117-124
|
artikel
|
| 44 |
Relationship between MTA1 and spread through air space and their joint influence on prognosis of patients with stage I-III lung adenocarcinoma
|
Liu, Yangyang
|
|
2018
|
124 |
C |
p. 211-218
|
artikel
|
| 45 |
Reply to Dickhoff et al. from authors of ‘Induction chemoradiotherapy versus chemotherapy alone for superior sulcus lung cancer’
|
Robinson, Lary A.
|
|
2018
|
124 |
C |
p. 322-323
|
artikel
|
| 46 |
Smoking, alcohol, and nutritional status in relation to one-year mortality in Danish stage I lung cancer patients
|
Christensen, Niels Lyhne
|
|
2018
|
124 |
C |
p. 40-44
|
artikel
|
| 47 |
Solitary pulmonary capillary hemangioma: An under-recognized pulmonary lesion mimicking early lung cancer on computed tomography images
|
Hsieh, Min-Shu
|
|
2018
|
124 |
C |
p. 227-232
|
artikel
|
| 48 |
Synchronous multiple non-small cell lung cancers in an allograft lung recipient
|
Pujol, Jean-Louis
|
|
2018
|
124 |
C |
p. 291-292
|
artikel
|
| 49 |
Targeted lung cancer screening selects individuals at high risk of cardiovascular disease
|
Balata, H.
|
|
2018
|
124 |
C |
p. 148-153
|
artikel
|
| 50 |
Tumor-specific genetic variants can be detected in circulating cell-free DNA of malignant pleural mesothelioma patients
|
Hylebos, Marieke
|
|
2018
|
124 |
C |
p. 19-22
|
artikel
|
Tijdschrift beschrijving